Skip to main content Skip to footer

Members Need The Right Drug At The Right Dose

Thirty-two million Americans are taking three or more prescription drugs.

Of those, 53 percent are taking the wrong drug or the wrong dose resulting in 7 million preventable medication errors, 7,000 preventable deaths, and $21B in direct annual medical costs.

And some of these are your members.


Fortunately, there’s a simple test that can drastically reduce those numbers.

Pharmacogenomic testing (PGx) – completed with a simple oral rinse – identifies how an individual’s unique genetic makeup reacts with specific drugs. Due to changes in DNA, many people have a slower response or no response at all to specific medications, while others may experience increased side-effects.

PGx makes it easier for your members and their doctors to find the right drug at the right dose without sometimes fatal, adverse pharmacy outcomes.

“Adverse Drug Interactions (ADI) are the fifth leading cause of death in the U.S., and Adverse Drug Reactions (ADR) cause more than 100,000 deaths per year,” says Dr. David Merritt, PharmD, RPh, chief pharmacist at Prescription Care Management.

“PGx testing can greatly decrease these outcomes by taking the guesswork out of prescribing,” he adds. “When patients avoid harmful drugs and are prescribed optimal drugs, their pharmacy outcomes are vastly more positive.”


A focus on finding the right drug at the right dose starts with you - the employer.

PGx reduces medical costs for physician visits and hospitalization, decreases member absenteeism for doctor visits and sick days, and creates a more healthful, productive workforce. But more importantly, it improves member health.

“Employers can foster a culture of pharmacy wellness by providing PGx testing for their high-risk members who consume most of their medical budget and have the greatest potential for adverse pharmacy outcomes,” says Merritt. “And as an added benefit, PGx can cut group drug spend.”


With PGx, you can find additional savings on medical costs while promoting a pharmacy benefit focused on reducing ADRs, improving member health and ultimately saving lives.

“We already have clients who are helping their members with this innovative approach,” adds Merritt. “PGx testing is a long-term solution to achieve better healthcare outcomes while decreasing drug and medical expenditures for the patient and client.”


To learn more about this innovative approach to improving outcomes and cutting costs, join us for our upcoming webinar ‘Pharmacogenomics: Reduced Drug Spend. Improved Health.’ on Tuesday, January 15 at 2 p.m. Register today.

Patty Starr bio image

About the author

Patty Starr

Patty Starr is president and CEO of Health Action Council and is responsible for driving the strategic direction of the organization--build stronger, healthier communities where business can thrive. 

Ready to take control of your employee healthcare & benefits costs?

We use cookies and similar technologies on our Website to ensure you the best browsing experience. Read about how we use cookies and how you can control them in our Privacy Statement. If you continue to use this site, you consent to our use of cookies. Go to Privacy